Boston, MA · Founded 2014 · Privately Held (backing)
Developer of topical therapies designed to address rare skin disorders associated with abnormal RAS pathway activity. NFlection Therapeutics is based in Boston, MA and was founded in 2014. It was valued at $156 million at its later-stage round in Aug 2025, the last priced event on record. It has raised $65.5 million across 3 recorded rounds; the latest was a $4 million seed round in Jul 2023.
PMV mark · valuation
$156.0M
Oct 2026
Priced at
its later-stage round
Aug 2025
Total raised
$65.5M
Last round
Seed Round
Jul 2023
No prints on record
No secondary trades in NFlection Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of NFlection Therapeutics with a free account
·Watch NFlection Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of NFlection Therapeutics stock.
